fluoroquinolone

The antibiotic fluoroquinolone was not used in poultry until 1995.

For example, a fluoroquinolone type medicine was registered and manufactured by more than 1,000 enterprises.

Some fluoroquinolone antibiotics have been shown to be photo co-carcinogens in an animal model.

The regulation of the fluoroquinolone antibiotics has presented novel challenges and concerns.

It is a second-generation fluoroquinolone with a broad spectrum of activity.

Currently, the fluoroquinolone antibiotics are the drugs of choice.

Resistance to ciprofloxacin (a fluoroquinolone), first identified in the early 1990s, continues to increase.

Monotherapy with a respiratory fluoroquinolone is the first choice.

"There has been ongoing work to update the labeling of the fluoroquinolone drug products," Cox said.

The same cholesterol drug appeared to make cells more sensitive to harm from the antibiotic fluoroquinolone.

Levofloxacin is a broad-spectrum antibiotic of the fluoroquinolone drug class.

Adverse reactions may manifest during, as well as after fluoroquinolone therapy.

Another fluoroquinolone, enrofloxacin, is used to treat respiratory illness in poultry.

Three days prior to the procedure, a patient is placed on oral fluoroquinolone, an antibacterial drug.

There are three known mechanisms of fluoroquinolone resistance.

Pruvelâ„¢ is a prodrug in the fluoroquinolone class of antibiotics being developed as a treatment for infectious diarrhea.

One in 1,500 people given a fluoroquinolone had acute kidney injury, twice as many as those not taking the drug.

Much of this can be linked to the use or overuse of Fluoroquinolone based antibiotics.

A major wide-ranged fluoroquinolone used in humans is ciprofloxacin.

Due to increased interest in Fluoroquinolone resistance, ciprofloxacin susceptibility testing results have been provided.

Resistance has developed in the newest members of the fluoroquinolone class, which have only been released for worldwide use in the last two years.

Where resistance is uncommon, the treatment of choice is a fluoroquinolone such as ciprofloxacin.

The basic pharmacophore, or active structure, of the fluoroquinolone class is based upon the quinoline ring system.

The illness is rarely fatal, but its main treatment is Cipro or a similar fluoroquinolone.

Most were found to bind near quantitatively to bone powder and released the parent fluoroquinolone at various rates.